These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37282444)
1. Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases. Almakadma AH; De Vol A; Alabdaljabar MS; Aldosari S; Muhsen I; AlFreihi O; Kurdi A; Almadi M; Alsohaibani F Saudi J Gastroenterol; 2023; 29(4):233-239. PubMed ID: 37282444 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478 [TBL] [Abstract][Full Text] [Related]
3. Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study. Nguyen GC; Croitoru K; Silverberg MS; Steinhart AH; Weizman AV Inflamm Bowel Dis; 2016 Jun; 22(6):1412-7. PubMed ID: 27120570 [TBL] [Abstract][Full Text] [Related]
4. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease]. Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244 [TBL] [Abstract][Full Text] [Related]
5. Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease: Cost is not the Only Factor! Banerjee R; Pal P; Adigopula B; Reddy DN J Clin Gastroenterol; 2021 Nov-Dec 01; 55(10):e92-e99. PubMed ID: 33405436 [TBL] [Abstract][Full Text] [Related]
6. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517 [TBL] [Abstract][Full Text] [Related]
8. Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002. Bauer N; Kairey L; Schlee C; Uecker C; Öznur Ö; Langhorst J Scand J Gastroenterol; 2022 Oct; 57(10):1209-1215. PubMed ID: 35722930 [TBL] [Abstract][Full Text] [Related]
9. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index. de Castro ML; Sanromán L; Martín A; Figueira M; Martínez N; Hernández V; Del Campo V; Pineda JR; Martínez-Cadilla J; Pereira S; Rodríguez Prada JI Rev Esp Enferm Dig; 2017 Aug; 109(8):542-551. PubMed ID: 28679280 [TBL] [Abstract][Full Text] [Related]
10. Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence. Brenner EJ; Long MD; Kappelman MD; Zhang X; Sandler RS; Barnes EL Dig Dis Sci; 2023 Jan; 68(1):58-64. PubMed ID: 35503483 [TBL] [Abstract][Full Text] [Related]
11. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Henriques DP; Oliveira RR; Vanni J; Lima HP; Otiti JV; Neves FRM; Hammerle MB; Sassaki LY; Zaltman C Arq Gastroenterol; 2022; 59(3):375-382. PubMed ID: 36102435 [TBL] [Abstract][Full Text] [Related]
12. Cannabis use amongst patients with inflammatory bowel disease. Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981 [TBL] [Abstract][Full Text] [Related]
13. Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease: A Comparison of Tools. Severs M; Zuithoff PN; Mangen MJ; van der Valk ME; Siersema PD; Fidder HH; Oldenburg B Inflamm Bowel Dis; 2016 Sep; 22(9):2158-64. PubMed ID: 27482979 [TBL] [Abstract][Full Text] [Related]
14. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey. Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360 [TBL] [Abstract][Full Text] [Related]
15. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey. Nahon S; Lahmek P; Saas C; Durance C; Olympie A; Lesgourgues B; Gendre JP Inflamm Bowel Dis; 2011 Jun; 17(6):1270-6. PubMed ID: 21560190 [TBL] [Abstract][Full Text] [Related]
16. The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases. Kluthe C; Tsui J; Spady D; Carroll M; Wine E; Huynh HQ Can J Gastroenterol Hepatol; 2018; 2018():4687041. PubMed ID: 29682493 [TBL] [Abstract][Full Text] [Related]
17. Identifying predictors of low adherence in patients with inflammatory bowel disease. Coenen S; Weyts E; Ballet V; Noman M; Van Assche G; Vermeire S; Van Emelen J; Ferrante M Eur J Gastroenterol Hepatol; 2016 May; 28(5):503-7. PubMed ID: 26760588 [TBL] [Abstract][Full Text] [Related]
18. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease. Selinger CP; Eaden J; Jones DB; Katelaris P; Chapman G; McDonald C; Smith P; Lal S; Leong RW; McLaughlin J; Robinson A Inflamm Bowel Dis; 2013 Sep; 19(10):2199-206. PubMed ID: 23899547 [TBL] [Abstract][Full Text] [Related]
19. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435 [TBL] [Abstract][Full Text] [Related]
20. Adherence to medical treatment in inflammatory bowel disease patients. Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]